About this trial
This study, in a quasi-experimental matched two-group pre-post design, investigates the effect of serial water-filtered whole-body hyperthermia on circadian core body temperature, the somatosensory system (nociception) and the movement evoked pain in healthy and patients with chronic primary pain (e.g., fibromyalgia). The intervention lasts 3 weeks with two treatment sessions per week.
Eligibility criteria
Qualifiers
Confirmed diagnosis of widespread pain (ICD-11 MG30.01)
Widespread Pain Index (WPI) ≥ 7 and Symptom Severity (SS) scale ≥ 5 or WPI) ≥ 3 and SS ≥ 9,
Pain >= 3 month and VAS >= 4,0
Body - infrared-A-Bulb Distance < 38cm (overweight participants)
Disqualifiers
Participation in other clinical studies
Contraindications for hyperthermia (severe cardiovascular diseases, tumour diseases, acute infections, pregnant and breastfeeding women)
Acute and / or feverish microbial infections
Participants with severe somatic, rheumatic concomitant endocrine or neurological diseases, in particular neurological diseases associated with cognitive disorders, severe liver or kidney and cardiac diseases
Trial design
Treatments tested in this trial
- serial whole body hyperthermia
Treatment groups
Sponsors and collaborators
Bern University of Applied Sciences
Lead sponsor
Dr. med. h.c Erwin Braun Stiftung
Collaborator